|211.00||+4.28||+2.07%||Vol 519.94K||1Y Perf -8.97%|
|May 13th, 2022 16:00 DELAYED|
|- -%||- -|
|Target Price||286.50||Analyst Rating||Moderate Buy 1.75|
|Potential %||35.78||Finscreener Ranking||★★ 46.21|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★ 40.70|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★★ 53.36|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Price Range Ratio 52W %||10.52||Earnings Rating||Neutral|
|Market Cap||17.15B||Earnings Date||27th Apr 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||2.48|
|EPS Growth Next 5 Years %||18.20|
|Avg. Weekly Volume||488.89K|
|Avg. Monthly Volume||466.51K|
|Avg. Quarterly Volume||626.74K|
ICON plc (NASDAQ: ICLR) stock closed at 211 per share at the end of the most recent trading day (a 2.07% change compared to the prior day closing price) with a volume of 519.94K shares and market capitalization of 17.15B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 15730 people. ICON plc CEO is Steven Cutler.
The one-year performance of ICON plc stock is -8.97%, while year-to-date (YTD) performance is -31.87%. ICLR stock has a five-year performance of 140.62%. Its 52-week range is between 199.01 and 313, which gives ICLR stock a 52-week price range ratio of 10.52%
ICON plc currently has a PE ratio of 86.30, a price-to-book (PB) ratio of 2.26, a price-to-sale (PS) ratio of 2.61, a price to cashflow ratio of 17.90, a PEG ratio of 2.32, a ROA of 1.64%, a ROC of 3.53% and a ROE of 3.40%. The company’s profit margin is 2.60%, its EBITDA margin is 12.00%, and its revenue ttm is $6.52 Billion , which makes it $80.26 revenue per share.
Of the last four earnings reports from ICON plc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.48 for the next earnings report. ICON plc’s next earnings report date is -.
The consensus rating of Wall Street analysts for ICON plc is Moderate Buy (1.75), with a target price of $286.5, which is +35.78% compared to the current price. The earnings rating for ICON plc stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
ICON plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
ICON plc has a Sell technical analysis rating based on Technical Indicators (ADX : 15.21, ATR14 : 10.35, CCI20 : -87.74, Chaikin Money Flow : -0.13, MACD : -8.27, Money Flow Index : 47.47, ROC : -1.93, RSI : 38.99, STOCH (14,3) : 34.73, STOCH RSI : 0.47, UO : 39.42, Williams %R : -65.27), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of ICON plc in the last 12-months were:
Sat, 30 Apr 2022 03:55 GMT Icon (ICLR) Gets a Buy Rating from Robert W. Baird- TipRanks. All rights reserved.
Sat, 05 Mar 2022 09:01 GMT Analysts Are Bullish on Top Healthcare Stocks: Icon (ICLR), IDEAYA Biosciences (IDYA)- TipRanks. All rights reserved.
Thu, 27 Jan 2022 16:35 GMT Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Icon (ICLR) and PDS Biotechnology (PDSB)- TipRanks. All rights reserved.
Wed, 19 Jan 2022 12:36 GMT Icon (ICLR) Gets a Buy Rating from Mizuho Securities- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.